Description

ARACHITOL INJ 3L IU (6*1ML)

Indications

Arachitol Injection 3L IU is primarily indicated for the treatment and prevention of vitamin D deficiency and insufficiency. It is particularly useful in conditions where increased vitamin D levels are necessary, such as osteoporosis, rickets, and osteomalacia. Additionally, it may be prescribed for patients with malabsorption syndromes or those who are on long-term corticosteroid therapy, which can impair vitamin D metabolism.

Mechanism of Action

Arachitol contains cholecalciferol, a form of vitamin D3 that plays a crucial role in calcium and phosphate homeostasis. Once administered, cholecalciferol is converted in the liver to 25-hydroxyvitamin D, and subsequently in the kidneys to its active form, 1,25-dihydroxyvitamin D. This active form enhances intestinal absorption of calcium and phosphate, promotes bone mineralization, and regulates parathyroid hormone levels, thereby contributing to overall bone health and metabolic function.

Pharmacological Properties

The pharmacokinetics of Arachitol Injection indicate that after intramuscular administration, cholecalciferol is rapidly absorbed and distributed throughout the body. The peak plasma concentration is typically reached within 24 to 48 hours. The half-life of vitamin D can vary significantly, ranging from several days to weeks, depending on individual metabolism and storage in adipose tissue. Arachitol is stored in the liver and fat tissues, allowing for a sustained release of vitamin D, which may help maintain adequate serum levels over time.

Contraindications

Arachitol Injection is contraindicated in patients with known hypersensitivity to vitamin D or any of its components. It should not be used in individuals with hypercalcemia, hyperphosphatemia, or vitamin D toxicity. Additionally, patients with certain conditions such as renal impairment or sarcoidosis should use this product with caution and under medical supervision, as these conditions can affect vitamin D metabolism and lead to adverse effects.

Side Effects

While Arachitol Injection is generally well tolerated, some patients may experience side effects. Common side effects include nausea, vomiting, and constipation. More serious adverse reactions can occur, such as hypercalcemia, which may present with symptoms like weakness, confusion, and kidney stones. It is important for patients to report any unusual symptoms to their healthcare provider promptly. Regular monitoring of serum calcium and phosphate levels is recommended during treatment to mitigate potential risks.

Dosage and Administration

The recommended dosage of Arachitol Injection varies depending on the indication and the patient’s individual needs. For adults, a typical dose for the treatment of vitamin D deficiency may range from 300,000 IU to 600,000 IU administered as a single intramuscular injection. For maintenance therapy, lower doses may be prescribed based on serum vitamin D levels. It is crucial to follow the healthcare provider’s instructions regarding dosage and frequency of administration. Arachitol should be administered by a qualified healthcare professional to ensure proper technique and monitoring.

Interactions

Arachitol Injection may interact with certain medications, which can affect its efficacy or increase the risk of side effects. For instance, anticonvulsants such as phenytoin and phenobarbital can accelerate the metabolism of vitamin D, potentially leading to decreased serum levels. Additionally, corticosteroids may reduce the effectiveness of vitamin D by impairing its metabolism. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before starting Arachitol Injection, it is essential to assess the patient’s medical history and any pre-existing conditions. Caution should be exercised in patients with a history of kidney disease, as they may be at increased risk of hypercalcemia. Regular monitoring of serum calcium levels is advisable, especially in patients receiving long-term treatment. Pregnant and breastfeeding women should also consult their healthcare provider before using this product, as high doses of vitamin D may pose risks to the fetus or infant.

Clinical Studies

Clinical studies have demonstrated the efficacy of vitamin D supplementation in improving bone health and reducing the incidence of fractures in at-risk populations. A study published in the Journal of Clinical Endocrinology & Metabolism found that high-dose vitamin D supplementation significantly improved bone mineral density in postmenopausal women with osteoporosis. Another study indicated that vitamin D administration could enhance muscle strength and reduce falls in elderly patients. These findings support the use of Arachitol Injection as an effective therapeutic option for managing vitamin D deficiency and its associated complications.

Conclusion

Arachitol Injection 3L IU is a valuable therapeutic agent for the prevention and treatment of vitamin D deficiency. Its mechanism of action, pharmacological properties, and clinical efficacy make it a crucial component in managing various bone health conditions. However, it is important for healthcare providers to monitor patients closely for potential side effects and interactions. By ensuring responsible use and adherence to prescribed dosages, Arachitol can significantly contribute to improved health outcomes in individuals at risk of vitamin D deficiency.